Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AcelRx Pharmaceuticals stock

Learn how to easily invest in AcelRx Pharmaceuticals stock.

AcelRx Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. AcelRx Pharmaceuticals shares (ACRX) are listed on the NASDAQ and all prices are listed in US Dollars. AcelRx Pharmaceuticals employs 43 staff and has a trailing 12-month revenue of around $2.9 million.

How to buy shares in AcelRx Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

AcelRx Pharmaceuticals stock price (NASDAQ: ACRX)

Use our graph to track the performance of ACRX stocks over time.

AcelRx Pharmaceuticals shares at a glance

Information last updated 2022-10-02.
Latest market close$0.22
52-week range$0.16 - $1.05
50-day moving average $0.26
200-day moving average $0.32
Wall St. target price$4.00
PE ratio 0.7464
Dividend yield $0 (0%)
Earnings per share (TTM) $0.28

Buy AcelRx Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AcelRx Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AcelRx Pharmaceuticals price performance over time

Historical closes compared with the close of $0.22 from 2022-10-03

1 week (2022-09-28) 0.22
1 month (2022-09-02) -26.67%
3 months (2022-07-05) -12.00%
6 months (2022-04-04) -24.14%
1 year (2021-10-01) N/A
2 years (2020-10-05) -83.58%
3 years (2019-10-04) 2.17
5 years (2017-10-04) 5.225

Is AcelRx Pharmaceuticals stock undervalued or overvalued?

Valuing AcelRx Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AcelRx Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AcelRx Pharmaceuticals's P/E ratio

AcelRx Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, AcelRx Pharmaceuticals shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

AcelRx Pharmaceuticals financials

Revenue TTM $2.9 million
Gross profit TTM $-1,748,000
Return on assets TTM -31.29%
Return on equity TTM 0%
Profit margin 1588.91%
Book value $0.23
Market capitalisation $30.8 million

TTM: trailing 12 months

AcelRx Pharmaceuticals share dividends

We're not expecting AcelRx Pharmaceuticals to pay a dividend over the next 12 months.

AcelRx Pharmaceuticals share price volatility

Over the last 12 months, AcelRx Pharmaceuticals's shares have ranged in value from as little as $0.16 up to $1.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AcelRx Pharmaceuticals's is 0.2693. This would suggest that AcelRx Pharmaceuticals's shares are less volatile than average (for this exchange).

AcelRx Pharmaceuticals overview

AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc.

Frequently asked questions

What percentage of AcelRx Pharmaceuticals is owned by insiders or institutions?
Currently 1.196% of AcelRx Pharmaceuticals shares are held by insiders and 11.791% by institutions.
How many people work for AcelRx Pharmaceuticals?
Latest data suggests 43 work at AcelRx Pharmaceuticals.
When does the fiscal year end for AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals's fiscal year ends in December.
Where is AcelRx Pharmaceuticals based?
AcelRx Pharmaceuticals's address is: 25821 Industrial Boulevard, Hayward, CA, United States, 94545
What is AcelRx Pharmaceuticals's ISIN number?
AcelRx Pharmaceuticals's international securities identification number is: US00444T1007
What is AcelRx Pharmaceuticals's CUSIP number?
AcelRx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00444T100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site